← Leaderboards
Matthew P Delisa
Vybion, Inc.
$2,745,626
Attributed
$3,952,716
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $755.3K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,952,716 · 8
By mechanism
R01$1,810,635 · 1
R21$1,492,380 · 4
S10$349,701 · 1
R41$300,000 · 2
Top collaborators
- Christopher Akinleye Alabi5 shared
- Matthew J Paszek5 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsBasePlayLibrariesEngineeringLifeAntibodiesMalignant NeoplasmsMolecularStructureAffinityReagentTechnologyInnovationBinding (Molecular Function)MediatingBacteriaBiological ProcessEnvironmentEpitopesCombinatorialCommunitiesInterest
Grant awards (18)
Molecular toolkit for high content resolution of glycomes by expansionmicroscopy$396,381
R01 · FY2023 · GM · contact PI
Molecular toolkit for high content resolution of glycomes by expansionmicroscopy$405,606
R01 · FY2022 · GM · contact PI
High-throughput label-free detection system for biomolecular interaction analysis$349,701
S10 · FY2022 · OD · contact PI
Molecular toolkit for high content resolution of glycomes by expansionmicroscopy$400,334
R01 · FY2021 · GM · contact PI
Molecular toolkit for high content resolution of glycomes by expansion microscopy$198,314
R01 · FY2021 · GM · contact PI
Molecular toolkit for high content resolution of glycomes by expansionmicroscopy$410,000
R01 · FY2020 · GM · contact PI
Proteolytic silencing of cancer targets using engineered ubiquitin ligases$169,836
R21 · FY2014 · CA · contact PI
Proteolytic silencing of cancer targets using engineered ubiquitin ligases$209,018
R21 · FY2013 · CA · contact PI
Discovery of antibodies that bind G protein-coupled receptors$198,750
R21 · FY2012 · DA · contact PI
Discovery of antibodies that bind G protein-coupled receptors$238,500
R21 · FY2011 · DA · contact PI
Rapid isolation of high-affinity human antibodies from large synthetic libraries$200,000
R41 · FY2010 · GM · contact PI
A new technology platform for studying protein function$168,260
R21 · FY2009 · CA · contact PI
A new technology platform for studying protein function$39,750
R21 · FY2009 · CA · contact PI
A new technology platform for studying protein function$191,266
R21 · FY2008 · CA · contact PI
A cell-based screen for inhibitors of intracellular Abeta aggregation$39,750
R21 · FY2008 · NS · contact PI
A cell-based screen for inhibitors of intracellular Abeta aggregation$39,750
R21 · FY2008 · NS · contact PI
A cell-based screen for inhibitors of intracellular Abeta aggregation$197,500
R21 · FY2006 · NS · contact PI
A novel biotherapeutic expression platform in bacteria$100,000
R41 · FY2005 · AI